23andMe Improves Research Consent Process
June 24, 2010
does not require IRB review. This would be true even if the federal government funded our work.While IRB approval is not required, we sought IRB approval for our research protocols and customer consent language to ensure that our work is in line with scientific research best practices. This has taken some time because 23andMe’s innovative new model of research was not originally anticipated by traditional IRB guidelines.So what has changed?The new IRB-approved consent process lets customers use our service and access their own data, regardless of whether or not they want to be part of research that will be published in a peer-reviewed scientific journal. Previously, customers opted into this research by purchasing our service, then completing and submitting surveys. Now, however, customers must explicitly choose to allow their genetic and survey data (in an aggregated and de-identified form, as always) to be used in published research.What hasn’t changed:23andMe remains committed to furthering personalized medicine. As such, we use data from all customers (including those who have not consented to be part of published studies) for company research aimed at making new discoveries and developing new features and products. This research is not intended for publication and is sometimes undertaken in association with our partners. We believe consumer-driven research will lead to significant findings that will benefit us all in the future.Visit the 23andMe website to read the full Consent Document, as well as updated versions of the Terms of Service and Privacy Statement.
You may also want to check out:
- PDGene Enters the Scene for Parkinson's Research
- Cilantro Love and Hate: Is it a Genetic Trait?
- Novel Genetic Findings for Myeloproliferative Neoplasms
- Science Advisor, Larry Smarr
- 23andMe Hangs out with the Lupus Research Institute
- Living With Crohn's and Colitis